SCHEMBL2890329

SCHEMBL2890329

CCCCCCCCC=CCCCCCCCCN1CC(C(=O)O)CC1=O.NCCOCCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 1/20 0.38
CNR2 P34972 2/20 0.38
TRPV1 Q8NER1 2/20 0.38
EPHX2 P34913 1/20 0.37
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CNR1 P21554 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
MGLL Q99685 3/20 0.35
FAAH O00519 1/20 0.35
HTT P42858 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2890322 1.00 L3MBTL1 (0.39) L3MBTL1SMN1; SMN2POLBCNR2TRPV1
Triethylene Glycol SCHEMBL1361572 0.94 EPHX2 (0.41) L3MBTL1SMN1; SMN2POLBCNR2TRPV1
Monoethanolamine SCHEMBL2889305 0.91 L3MBTL1 (0.43) L3MBTL1SMN1; SMN2POLBCYP2C19MEN1
SCHEMBL688297 0.86 POLB (0.49) L3MBTL1SMN1; SMN2POLBCYP2C19MEN1
SCHEMBL1360713 0.86 POLB (0.49) L3MBTL1SMN1; SMN2POLBCYP2C19MEN1
SCHEMBL2890328 0.85 CNR2 (0.41) POLBCNR2TRPV1EPHX2CYP2C19
Monoethanolamine SCHEMBL2890477 0.84 POLB (0.49) L3MBTL1SMN1; SMN2POLBCYP2C19MEN1
SCHEMBL2889307 0.82 POLB (0.49) L3MBTL1SMN1; SMN2POLBCYP2C19MEN1
Glycerin SCHEMBL3844851 0.81 POLB (0.45) L3MBTL1SMN1; SMN2POLBCYP2C19MEN1
SCHEMBL15082397 0.80 L3MBTL1 (0.51) L3MBTL1SMN1; SMN2POLBCYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349215-B2 Corrosion inhibitors having increased biological degradability and minimized toxicity CLARIANT FINANCE (BVI) LIMITED (VG) 2013-01-08 US disclosed
US-20100283010-A1 Corrosion Inhibitors Having Increased Biological Degradability And Minimized Toxicity CLARIANT FINANCE (BVI) LIMITED (VG) 2010-11-11 US disclosed